Meeting
2018 ASCO Annual Meeting
Prospective phase II multicenter trial of ablation after breast lumpectomy added to treat (ABLATE) breast cancer without radiation.
Authors
V. Suzanne Klimberg
University of Arkansas for Medical Sciences, Little Rock, AR
V. Suzanne Klimberg , Kristalyn Gallagher , Sheldon M. Feldman , Jeanette Y. Lee , Daniela A Ochoa , Joshua Matthew Varghise Mammen , Ronda S. Henry-Tillman , Tom Frazier , Marilee McGinness , Julie Barone , Robert M. Barone , Soheila Korourian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Local-Regional Therapy
Clinical Trial Registration Number
01153035
Citation
J Clin Oncol 36, 2018 (suppl; abstr 562)
DOI
10.1200/JCO.2018.36.15_suppl.562
Abstract #
562
Poster Bd #
54
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Adherence to hormonal therapy among commercially insured breast cancer patients.
First Author: Hui Zhao
Poster
2015 Breast Cancer Symposium
Tubular carcinoma of the breast: A single institution's experience of prognosis.
First Author: William P Boyan Jr.
Poster
2023 ASCO Annual Meeting
Dares: A phase II trial of durvalumab and ablative radiation in extensive stage small cell lung cancer.
First Author: Aditya Juloori
Poster
2023 ASCO Annual Meeting
Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.
First Author: Gustavo Schvartsman